My ePortfolio Register   

Axillary dissection may be overtreatment in some breast cancer patients

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.12.11
Views: 3988
Rating:

Dr Viviana Galimberti - European Institute of Oncology, Milan, Italy

Dr Viviana Galimberti talks to ecancer.tv about the IBCSG (International Breast Cancer Study Group) 2301 trial evaluating the need for axillary dissection in patients with clinically negative node breast cancer or sentinel node micrometastases. Patients were randomised to either axillary dissection or to no further treatment and it was shown that axillary dissection was not superior in terms of disease free survival. Dr Galimberti explains that although these are only preliminary results, they do suggest that axillary dissection is an overtreatment in these patients

Categories:

Breast · Surgery · SABCS 2011

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence